Company Valuation: APT Medical Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 18,668 20,463 25,854 36,094 33,135 33,135 -
Change - 9.62% 26.35% 39.61% -8.2% 0% -
Enterprise Value (EV) 1 18,668 20,463 25,854 36,094 32,045 31,766 31,190
Change - 9.62% 26.35% 39.61% -11.22% -0.87% -1.81%
P/E ratio 90.3x 57.9x 48.4x 53.5x 39.7x 30.3x 23.5x
PBR 10.5x 11.6x 13.6x 14.4x 11.1x 8.56x 6.49x
PEG 2.3x 0.8x 0.9x 2.1x 1.7x 1x 0.8x
Capitalization / Revenue 22.5x 16.8x 15.7x 17.5x 13.3x 9.91x 7.76x
EV / Revenue 22.5x 16.8x 15.7x 17.5x 12.3x 9.51x 7.3x
EV / EBITDA 74.2x 46.4x 38.9x 43.8x 31x 23.2x 18.1x
EV / EBIT 84.4x 51.5x 42.5x 47.9x 34.5x 25.9x 19.8x
EV / FCF 1,329x 91.2x - - 265x 794x 37.9x
FCF Yield 0.08% 1.1% - - 0.38% 0.13% 2.64%
Dividend per Share 2 0.4756 0.7848 0.9512 1.207 1.471 1.814 2.318
Rate of return 0.36% 0.54% 0.51% 0.47% 0.63% 0.77% 0.99%
EPS 2 1.474 2.521 3.815 4.8 5.912 7.753 9.992
Distribution rate 32.3% 31.1% 24.9% 25.1% 24.9% 23.4% 23.2%
Net sales 1 828.7 1,216 1,651 2,066 2,584 3,342 4,271
EBITDA 1 251.4 440.9 665.1 824.7 1,032 1,367 1,727
EBIT 1 221.3 397 608.2 754 943.9 1,225 1,575
Net income 1 206.6 358 535.6 673.5 820.6 1,093 1,409
Net Debt 1 - - - - -1,090 -1,369 -1,945
Reference price 2 133.17 145.98 184.78 256.78 234.95 234.95 234.95
Nbr of stocks (in thousands) 140,174 140,174 139,920 140,565 141,030 141,030 -
Announcement Date 24/02/22 23/02/23 23/02/24 24/02/25 26/02/26 - -
1CNY in Million2CNY
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
39.74x12.34x31.04x0.63% 4.8B
66.37x7.97x42.61x-.--% 13.19B
35.46x - - -.--% 9.16B
20.23x1.71x9.07x2.6% 5.46B
18.8x3.41x12.53x1.72% 5.25B
29.26x5.61x16.09x1.36% 5.14B
46.24x - - - 1.81B
25.71x2.43x9.89x1.98% 1.42B
-7.99x1.67x-7.86x - 1.37B
Average 30.43x 5.02x 16.20x 1.18% 5.29B
Weighted average by Cap. 39.08x 6.18x 24.91x 0.81%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. 688617 Stock
  4. Valuation APT Medical Inc.
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW